申请人:Che Jianwei
公开号:US20120184526A1
公开(公告)日:2012-07-19
Provided herein are a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated Syk kinase activity.
本文提供了一类新型化合物,包括这些化合物的药物组成物和使用这些化合物治疗或预防与异常或非规则Syk激酶活性相关的疾病或障碍的方法。